The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity
J. Clin. Invest. Benoit Viollet, et al. 111:91
doi:10.1172/JCI16567 [Go to this article.]

Figure 2
AMPKα2–/– mice are AICAR-resistant, glucose intolerant, and exhibit impaired glucose-stimulated insulin secretion. (a) AICAR tolerance test. (b) OGTT. (c) Plasma glucose and insulin levels at time 20 minutes during OGTT. All results are expressed as mean ± SEM (n = 6–10). *P < 0.05, **P < 0.001, ***P < 0.0001 vs. control group by unpaired, two-tailed Student t test. NS, not significant.